Study: Latent Epstein-Barr Virus (EBV) Infection May Lead to Heart Problems
Study showed that latent EBV Reactivation Could Cause Heart Disease
If your doctor belongs to our network of doctors, you are entitled to a discount. When ordering, please tell us the name of your doctor and we will check for you.
We accept all types of credit cards (credit, debit, pre-paid, etc.). Sorry, we don't accept other modes of payment.
We can also take your order over the phone. Call us if you would like to use this option.
To keep your privacy, your bank or credit card statements will only show the name of our parent company, not the product.
For your security, we will never call you and ask for your credit card number, or personal information.
See more details about Gene-Eden-VIR/Novirin in Package Insert.
Call us and ask about promotions
The Center for the Biology of Chronic Disease (CBCD), recently learned that
according to HealthCanal.com, "A new study could provide the link that scientists have been looking for to
confirm that reactivation of a latent herpes
virus is a cause of some heart problems."
The CBCD has, for many years, believed that viruses in their latent form are the
cause of many major diseases. This includes the Epstein Barr virus (EBV).
The study mentioned above went on to say, "Looking
at blood samples from 299 heart patients, researchers at Ohio
State University found that those who had suffered a heart attack were the most likely to have
inflammatory proteins circulating in their blood compared to patients with less
acute symptoms. And having more of one of these proteins in the blood was linked to the presence
of antibodies that signal a latent Epstein-Barr
virus (EBV) reactivation. To date, these relationships have been hard to find because scientists have been unable
to detect evidence of a virus in diseased areas of the cardiovascular system."
However, the CBCD has shown how the DNA of latent viruses can cause major diseases such
as heart disease.
According to Dr. Hanan Polansky's theory of Microcompetition, fragments
of DNA, called N-boxes, can be dangerous. When foreign N-boxes enter the
body (naturally, or artificially, like through an injection of some treatment),
they end up in the nucleus, where they attract scarce genetic resources. It is
interesting that many common latent viruses have strong N-boxes in
They include the Epstein-Barr virus (EBV), Cytomegalovirus (CMV), Herpes Simplex
virus (HSV), Varicella Zoster virus (VZV), Hepatitis B Virus (HBV), Hepatitis C
Virus (HCV), Human Papillomavirus (HPV), and others. In fact, the CMV virus has
the strongest N-box known to science. This N-box is so strong that human genes
cannot compete with its power to attract the scarce genetic resources.
What can one do to target the latent form of the Epstein Barr Virus (EBV)?
The CBCD proposes a scientific, natural, antiviral remedy that boosts the immune
system against the latent Epstein Barr Virus (EBV).
"The key to your health is to reduce the level of the latent viruses in your
body to harmless levels." - Dr. Hanan Polansky
The name of that antiviral remedy is Gene-Eden-VIR.
This all-natural product was scientifically designed to help the immune system target the latent Epstein
Barr virus (EBV).
Gene-Eden-VIR is effective against the latent Epstein Barr virus. Each ingredient was chosen
through a scientific approach. Scientists scanned thousands of scientific and
medical papers published in various medical and scientific journals around the
world to identify safe and effective natural ingredients that target the
Gene-Eden-VIR is safe. It has been on the market for over three years, and in that time, no side effects
were reported. Each capsule contains a patented formula of five all natural
ingredients including selenium, camellia sinesis extract, quercetin, cinnamomum
extract, and licorice extract. In addition, each bottle is GMP Certified.
Gene-Eden-VIR is sold online through the Gene-Eden website. Each bottle of Gene-Eden-VIR (a one
month's supply) costs $42.99.
To learn more about Gene-Eden-VIR, the only product on the market today that helps the body
target the latent Epstein Barr virus (EBV), and that is scientifically backed by published material, visit
the Gene-Eden-VIR website.
Note: This press release was first issued by The Center for the
Biology of Chronic Disease (CBCD), a not-for-profit organization that specializes
in researching the biology of foreign DNA.